September 21, 2016
1 min read
Save

Complications, transfusion associated with discharge to post-acute care after TJA

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients had significantly higher odds of being discharged to a post-acute care setting, which increased incremental costs for a 90-day episode of care, if they experienced a complication or received a transfusion during the index hospitalization of total joint arthroplasty, according to results.

Using the MarketScan Commercial Research Database, researchers identified 526,481 adult patients who underwent either a primary unilateral total knee arthroplasty (TKA, 61.5%), primary unilateral total hip arthroplasty (THA, 30.3%), revision TKA (4.8%) or revision THA (3.4%) and had continuous health plan enrollment from 3 months prior to surgery through 3-month follow-up. Researchers analyzed factors associated with discharge destination and risk of readmission using logistic regression and Cox proportional hazard models and calculated total 90-day costs for different patient pathways of care, dependent on complications, discharge destination and readmission status.

Results showed all-cause complications occurred in 2.5% of patients who underwent primary TKA, 37.2% of patients who underwent revision TKA, 2.6% of patients who underwent primary THA and 35% of patients who underwent revision THA. Patients who experienced complications, transfusions or a length of stay of 3 days or longer had greater odds of being discharged home with home health services or to a skilled nursing facility vs. home under self-care, researchers found. According to results, a greater risk of readmission was associated with patients who were discharged home with home health services or to a skilled nursing facility. Researchers noted a ratio that ranged from 1.8 to 2.2 for the total 90-day costs for the highest- vs. lowest-cost care pathways. – by Casey Tingle

 

Disclosures: Nichols is a paid employee of Medtronic Advanced Energy Inc. and has stock with Medtronic Inc. Please see the full study for a list of all other authors relevant financial disclosures.